In high- and standard-risk patients CAS and TCAR look good, but some worry about skill sets, learning curves, and ...

There’s no “silver bullet” for this problem, which is largely driven by clinical inertia, but some efforts are chipping away ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

Private equity is taking on a much larger role within cardiology, the 12th annual cardiovascular provider compensation and ...

Just 15% of patients have their filters taken out despite clear recommendations they should be removed as soon as feasible.

The results in patients with long, complex lesions are better than or equal to those of surgery, but without the ...

Women who experience hypertensive disorders of pregnancy (HDP) go on to develop CAD earlier in life compared with women who ...

The STS/ACC TVT Registry data should alleviate prior concerns about the appropriateness of choosing TAVI for young patients.

No matter whether patients had CAD or not, the simpler regimen was linked to less mortality and major bleeding at 6 months.

The change reflects a growing understanding of what resources are needed to offer these scans and will likely improve access.

The CLEAR-IE registry data, which show clinical efficacy, are just the first step—an RCT may be forthcoming, researchers say.